David Summa is an accomplished executive with extensive experience in transforming disruptive technologies into thriving businesses. They served as CEO of Acumen Pharmaceuticals, negotiating a significant R&D collaboration with Merck, and led multiple successful financing initiatives. Currently, as Chief Business Officer at Phizzle, David works on establishing the company's commercial foundation. David has also held leadership roles at Genoa Ventures and Ionpath, contributing to various boards and advisory positions throughout their career. An MIT alumnus, David holds multiple degrees in Chemical Engineering, highlighting their commitment to technology and innovation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices